These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of vasopressin on memory following electroconvulsive therapy. Lerer B; Zabow T; Egnal N; Belmaker RH Biol Psychiatry; 1983 Jul; 18(7):821-4. PubMed ID: 6615939 [No Abstract] [Full Text] [Related]
3. Oxytocin and vasopressin responses to ECT. Smith JE; Williams K; Burkett S; Glue P; Nutt DJ Psychiatry Res; 1990 May; 32(2):201-2. PubMed ID: 2367605 [No Abstract] [Full Text] [Related]
4. Vasopressin in depression. Raskind M; Orenstein H; Weitzman RE Lancet; 1979 Jan; 1(8108):164. PubMed ID: 84191 [No Abstract] [Full Text] [Related]
5. Improvement in depressive illness is not associated with altered release of neurophysins over a course of ECT. Scott AI; Shering PA; Legros JJ; Whalley LJ Psychiatry Res; 1991 Jan; 36(1):65-73. PubMed ID: 2017524 [TBL] [Abstract][Full Text] [Related]
10. Electroconvulsive therapy and brain-derived neurotrophic factor. Scott A J ECT; 2011 Mar; 27(1):92; author reply 92-3. PubMed ID: 21336057 [No Abstract] [Full Text] [Related]
11. Changes in platelet 3H-imipramine binding in depressed patients receiving electroconvulsive therapy. Maj M; Mastronardi P; Cerreta A; Romano M; Mazzarella B; Kemali D Biol Psychiatry; 1988 Aug; 24(4):469-72. PubMed ID: 2841987 [No Abstract] [Full Text] [Related]
12. Effects of electroconvulsive therapy on plasma vasopressin and oxytocin. Devanand DP; Lisanby S; Lo ES; Fitzsimons L; Cooper TB; Halbreich U; Sackeim HA Biol Psychiatry; 1998 Oct; 44(7):610-6. PubMed ID: 9787885 [TBL] [Abstract][Full Text] [Related]
13. Effects of electroconvulsive treatment on monoamine metabolites, growth hormone, and prolactin in plasma. Linnoila M; Litovitz G; Scheinin M; Chang MD; Cutler NR Biol Psychiatry; 1984 Jan; 19(1):79-84. PubMed ID: 6200149 [No Abstract] [Full Text] [Related]
14. The effect of electroconvulsive therapy on plasma cyclic-AMP, non-esterified fatty acid, tryptophan and tyrosine in depression. Sawa Y Keio J Med; 1981 Nov; 30(4):193-204. PubMed ID: 6290737 [No Abstract] [Full Text] [Related]
15. Hormone pattern and post-treatment attitudes in patients with major depressive disorder given electroconvulsive therapy. Apéria B Acta Psychiatr Scand; 1986 Mar; 73(3):271-4. PubMed ID: 3012951 [TBL] [Abstract][Full Text] [Related]
16. Plasma pattern of adrenocorticotropin and cortisol during electroconvulsive therapy in patients with major depressive illness. Apéria B; Thorén M; Zettergren M; Wetterberg L Acta Psychiatr Scand; 1984 Oct; 70(4):361-9. PubMed ID: 6093435 [TBL] [Abstract][Full Text] [Related]
17. Serial monitoring of antidepressant response to electroconvulsive therapy with sleep EEG recordings and dexamethasone suppression tests. Grunhaus L; Tiongco D; Roehrich H; Eiser A; Feinberg M; Greden JF Biol Psychiatry; 1985 Jul; 20(7):805-8. PubMed ID: 4005338 [No Abstract] [Full Text] [Related]
18. Current intensity and oxytocin release after electroconvulsive therapy. Riddle WJ; Scott AI; Bennie J; Carroll S; Fink G Biol Psychiatry; 1993 Jun 1-15; 33(11-12):839-41. PubMed ID: 8373922 [No Abstract] [Full Text] [Related]
19. Methysergide reduces the prolactin response to ECT. Papakostas Y; Markianos M; Stefanis C Biol Psychiatry; 1988 Aug; 24(4):465-8. PubMed ID: 3408764 [No Abstract] [Full Text] [Related]
20. Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: II. Effects of pretreatment regimens on catecholamines, ACTH, vasopressin, and cortisol. Weinger MB; Partridge BL; Hauger R; Mirow A; Brown M Anesth Analg; 1991 Nov; 73(5):563-9. PubMed ID: 1659253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]